H.R. 3 would ensure drug companies charge a fair price to patients while protecting access to lifesaving drugs and innovation.
On the recordSeptember 25, 2019
Source
congress.govEditor's note · Context
H.R. 3 aims to balance fair pricing with drug access.
Share & report
More from Frederica Wilson
Mar 22, 2023
The work we do here today has direct consequences on your lives and futures. I hope all my colleagues will keep today's hearing grounded in our most important priority: supporting your success and pursuit of the American Dream.
Jul 26, 2023
We are the Education Committee, and we have done nothing to ensure that hungry students in our classrooms and college campuses have access to food so that they can learn and not worry about going hungry.
May 10, 2023
We cannot afford to fall behind in this critical area, and increasing our investment is the only way to stay competitive.





